Our combination of comprehensive tumor markers and harmonized instrument families provide your laboratory with clinically relevant results for the most debilitating, costly and commonly occurring cancers. Rediscover personalized oncology testing solutions for early detection, diagnosis and monitoring needs. 

For in vitro diagnostic use only.

Early detection

The clinical laboratory can play a key role in the early detection of cancer, which may greatly increase the chances of successful treatment.

Effective management

Oncology biomarkers can provide affordable, reliable, accurate, non-invasive, and sensitive information to help effectively manage cancer.

Oncology biomarkers

Approximately 1 in 5 women will develop a pelvic mass in their lifetime. The Risk of Ovarian Malignancy Algorithm (ROMA) calculation can help determine the likelihood that this mass is a malignancy prior to surgery.

The global burden of ovarian cancer

Epithelial ovarian cancer is the fifth leading cause of cancer deaths in women worldwide.1 Due to current testing limitations and its non-specific symptoms, ovarian cancer is diagnosed at an advanced stage in more than 70% of patients.2 The associated poor prognosis and intensive treatment pathway places a heavy burden on patients, their caregivers, and their loved ones.

But it doesn’t always have to be like this.

For many women facing ovarian cancer, we can help clinicians make more informed decisions for their patients on risk stratification, monitoring and recurrence of progressive disease.

Because it's more than a test. It's her life.

Assays engineered to provide reliable assistance in cancer diagnosis and monitoring of patient response to therapy

Abbott offers a wide variety of assays to test for many types of cancers including, breast, colon, gastrointestinal, liver, ovarian, pancreatic, testicular and prostate cancer. The Abbott oncology solution can help you reduce laboratory operational costs while maintaining the quality standards necessary to have a meaningful positive impact to the quality and cost of health care.

Core laboratory menu
Register or Login To your account to view assay specific package inserts for intended use and important safety information.
Some assays may not be available on all platforms.
Beta2 Microglobulin
CA 125 II
CA 15-3
CA 19-9 (CA 19-9 XR)
PSA, Free
PSA, Total


Learning Guides

Build key laboratory competencies and explore topics from various disciplines with our learning guides.

Customer Portal

Receive exclusive benefits and resources when you register to access to the customer portal.

Contact Us

Abbott's Representatives are ready to offer support, gather feedback, and answer any questions.


  1. Brodsky BS, Owens GM, Scotti DJ, et al. Economic Impact of Increased Utilization of Multivariate Assay Testing to Guide the Treatment of Ovarian Cancer: Implications for Payers. Am Health Drug Benefits. 2017;10(7):351-9.

  2. Chan JK, Teoh D, Hu JM, et al. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol. 2008;109(3):370-6.